Sreeven Pharma Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 1992.
1992 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Sreeven Pharma Private Limited

Sreeven Pharma Private Limited, a active private limited company, was established on 08 July 1992 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U65993TG1992PTC014481. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.69 Cr.

Formerly known as Richie Investments & Consultants Pvt Ltd. It upholds a compliant status. Its leadership includes Sandeep Gokaraju (Director), Devendrappa Jegashetty (Managing Director). Past directors included Sandeep Gokaraju, Deelip Sidramappa Patil, Suryakanth Patil. It holds ₹6.00 Cr open charges and ₹9.06 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H.No. 11-15-25, Doctors Colony Lb Nagar, Hyderabad, Telangana, 500074.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U65993TG1992PTC014481

  • Registration Number

    014481

  • Incorporation Date

    08 July 1992

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹3.69 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 3.69 Cr
  • Company Age 33 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 6.00 Cr
  • Satisfied Charges ₹ 9.06 Cr
  • Revenue Growth **** -98.86%
  • Profit Growth **** -20.61%
  • Ebitda **** -187.64%
  • Net Worth -1143.23%
  • Total Assets -20.67%
Company report

Sreeven Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sreeven Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sreeven Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sandeep Gokaraju Director 15 Jul 2022 Current
Devendrappa Jegashetty Managing Director 11 Apr 2003 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director 27 Nov 2013 Past
Pramod Abcsdd Director 22 Apr 2024 Past
Pramod Abcsdd Director 30 Mar 2013 Past
Pramod Abcsdd Director 22 Apr 2024 Past
Pramod Abcsdd Director 30 Mar 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sreeven Pharma.

Sreeven Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 98.86% decrease. The company also saw a substantial fall in profitability, with a 20.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1143.23%.

Sreeven Pharma revenue growth over time
Sreeven Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -98.86%
*******
*******
*******
*******
Revenue from Operations
*******
 -98.87%
*******
*******
*******
*******
Total Assets
*******
 -20.67%
*******
*******
*******
*******
Profit or Loss
*******
 -20.61%
*******
*******
*******
*******
Net Worth
*******
 -1143.23%
*******
*******
*******
*******
EBITDA
*******
 -187.64%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sreeven Pharma?

Unlock access to Sreeven Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹60,000,000.00

Satisfied Charges

₹90,600,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 6.00 Cr
Latest Charge Details
Date Lender Amount Status
19 Aug 2024 Axis Bank Limited ₹6.00 Cr Open
27 Jan 2017 Syndicate Bank ₹1.20 Cr Satisfied
22 Feb 2016 Canara Bank ₹4.95 Cr Satisfied
26 Aug 2011 Axis Bank Limited ₹2.21 Cr Satisfied
31 Oct 2008 Syndicate Bank ₹7.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sreeven Pharma?

Unlock and access historical data on people associated with Sreeven Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sreeven Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sreeven Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sreeven Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Sreeven Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Sreeven Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 6.00 Cr with Charge ID 100972431 was registered on 19 Aug 2024. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 27 Jan 2017 via Charge ID 100083574 with Syndicate Bank was fully satisfied on 10 Oct 2022. was documented.

  • Charges

    Progress on A charge registered on 22 Feb 2016 via Charge ID 10627736 with Canara Bank was fully satisfied on 10 Oct 2022. was documented.

  • Director Appointment

    Progress on Sandeep Gokaraju was appointed as a Director was appointed as a Director on 15 Jul 2022 & has been associated with this company since 3 years 7 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sreeven Pharma Private Limited?

The CIN of Sreeven Pharma Private Limited is U65993TG1992PTC014481.

Where is Sreeven Pharma Private Limited headquartered?

Sreeven Pharma Private Limited is headquartered at H.No. 11-15-25, Doctors Colony Lb Nagar, Hyderabad, Telangana, 500074.

When was Sreeven Pharma Private Limited incorporated?

Sreeven Pharma Private Limited was incorporated on 08 July 1992.

Who are the current directors of Sreeven Pharma Private Limited?

The current directors of Sreeven Pharma Private Limited are

What is the primary industry of Sreeven Pharma Private Limited?

The primary industry of Sreeven Pharma Private Limited is Trade.

Is Sreeven Pharma Private Limited a listed company?

Sreeven Pharma Private Limited is unlisted.

What is the capital structure of Sreeven Pharma Private Limited?

The authorized capital of Sreeven Pharma Private Limited is ₹5.00 Cr, and the paid-up capital is ₹3.69 Cr.

What is the compliance status of Sreeven Pharma Private Limited?

The compliance status of Sreeven Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available